blog

Learn 5 practical strategies to reduce AI hallucination in clinical research to improve accuracy, transparency, compliance, and decision-making.

See how Altasciences’ Acceleration Platform helped advance an incretin-based therapy to POC in ~22 months through integrated drug development.

Explore pragmatic strategies for assessing physical withdrawal in clinical trials, including study design challenges, measurement tools, and patient-centric solutions.

Jeff Plomley discusses how patient-centric blood microsampling can enable at-home, minimally invasive sample collection, and improve accessibility and clinical trial efficiency.

Discover translational pharmacology strategies from industry expert to improve target validation, PK/PD understanding, and animal-to-human translation in early-phase drug development.

Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.

Discover how clinic-ready manufacturing and adaptive clinical trials streamline drug development, prevent delays, conserve your resources, and ensure safety, compliance, and efficiency.